Symposia: Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
immune mechanism, Diseases, immunology, Myeloid Malignancies, Biological Processes, molecular biology, Minimal Residual Disease
Type: Oral
Hematology Disease Topics & Pathways:
immune mechanism, Diseases, immunology, Myeloid Malignancies, Biological Processes, molecular biology, Minimal Residual Disease
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Room 6CF
(San Diego Convention Center)
Moderators:
Lina Benajiba, MD, PhD, Université Paris Cité, APHP, Hôpital Saint-Louis
and
Sergio Rutella, MD, PhD, FRCPath, Nottingham Trent University
Disclosures:
Benajiba: Gilead: Research Funding; Pfizer: Research Funding; GSK: Honoraria; BMS: Honoraria. Rutella: Wugen: Research Funding.
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH